The abbreviation refers to Tenecteplase , a genetically modified version of alteplase that has gained FDA approval for treating acute ischemic stroke (AIS) as of May 2025.
Navigating the "EVDCV1 TNK zip" Download: A Guide for Clinicians
Here is a blog post looking at the context and safety considerations of this download.